91 related articles for article (PubMed ID: 23104756)
1. Timing of antiretrovirals in opportunistic infections.
Thornhill J; Aboud M
Int J STD AIDS; 2012 Oct; 23(10):760. PubMed ID: 23104756
[No Abstract] [Full Text] [Related]
2. HIV/AIDS.
Saag MS; Masur H
Infect Dis Clin North Am; 2014 Sep; 28(3):xv-xvi. PubMed ID: 25151570
[No Abstract] [Full Text] [Related]
3. Timing of antiretroviral drugs during tuberculosis therapy.
Wilson D; Meintjes G
N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
[No Abstract] [Full Text] [Related]
4. Timing of antiretroviral drugs during tuberculosis therapy.
Kadhiravan T
N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
[No Abstract] [Full Text] [Related]
5. Opportunistic infections in the era of highly active antiretroviral therapy.
Ferri RS
Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517
[No Abstract] [Full Text] [Related]
6. Timing of antiretroviral drugs during tuberculosis therapy.
Garcia-Vidal C; Salvado M; Salavert M
N Engl J Med; 2010 Jun; 362(22):2137-8; author reply 2138-9. PubMed ID: 20527080
[No Abstract] [Full Text] [Related]
7. Current use of antiretroviral treatment.
Bailey AC; Fisher M
Br Med Bull; 2008; 87():175-92. PubMed ID: 18757468
[TBL] [Abstract][Full Text] [Related]
8. Advances in antiretroviral therapy.
Taylor B; Olender S; Wilkin TJ; Hammer SM
Top Antivir Med; 2011; 19(2):69-97. PubMed ID: 21868824
[TBL] [Abstract][Full Text] [Related]
9. [Antiretroviral therapy of HIV infection].
Imamura A
Nihon Rinsho; 2012 Apr; 70(4):601-6. PubMed ID: 22568140
[TBL] [Abstract][Full Text] [Related]
10. The long-term consequences of antiretroviral therapy.
Smith D
J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
[No Abstract] [Full Text] [Related]
11. Reducing central nervous system complications associated with the human immunodeficiency virus.
Mclauchlan D; Robertson NP
J Neurol; 2014 Sep; 261(9):1842-5. PubMed ID: 25119844
[No Abstract] [Full Text] [Related]
12. [HIV-infection].
Wasmuth JC; Rockstroh JK
Dtsch Med Wochenschr; 2007 Mar; 132(13):673-83; quiz 685-6. PubMed ID: 17377882
[No Abstract] [Full Text] [Related]
13. 30 years after HIV identification: where to from here?
Stover J
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):947-9. PubMed ID: 22029511
[No Abstract] [Full Text] [Related]
14. Profile of HIV associated tuberculosis at a tertiary institute in setting of free anti-retroviral therapy.
Agarwal U; Kumar A; Behera D
J Assoc Physicians India; 2009 Oct; 57():685-90. PubMed ID: 20329424
[TBL] [Abstract][Full Text] [Related]
15. New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B.
Soriano V; Vispo E; Barreiro P
AIDS; 2011 Apr; 25(7):1013-4. PubMed ID: 21487255
[No Abstract] [Full Text] [Related]
16. Treatment. Individual approach needed for co-infections.
AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
[No Abstract] [Full Text] [Related]
17. A dramatic change in HIV treatment.
Wilkins K; Maurer T; Berger T
J Drugs Dermatol; 2004; 3(4):452-5. PubMed ID: 15303794
[No Abstract] [Full Text] [Related]
18. Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis.
Chilton D; Edwards SG; Pellegrino P; Miller RF
Thorax; 2008 Oct; 63(10):935-6. PubMed ID: 18820121
[No Abstract] [Full Text] [Related]
19. Usefulness of an observational database to assess antiretroviral treatment trends in India.
Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of antituberculosis treatments at 18 months follow-up in TB-HIV co-infected patients on ART: a retrospective review of 166 cases.
Chunpongthong P; Ko ZZ; Yeekian C; Luvira V; Pitisuttithum P
J Med Assoc Thai; 2011 Jun; 94(6):664-70. PubMed ID: 21696073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
